"HIV is not 'over' as the situation across the Western Pacific clearly shows," said Saia Ma'u Piukala, WHO regional director for the Western Pacific, stressing the need "for strategic and targeted ...
Despite meaningful progress in HIV prevention, the HIV epidemic is far from over, with 31,000 new diagnoses in the U.S. each ...
Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
We finally have the technology, infrastructure, and the political will to end the US HIV epidemic, write the Brown University ...
The announcement coincides with the expansion of the NHS Blood Borne Virus Opt-out Testing programme, which now includes 89 ...
The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in ...
Researchers at the University of Cologne have identified a potent antibody – 04_A06 – which neutralised nearly all tested HIV ...
The antibody, called 04_A06, blocked 98.5% of more than 300 different HIV strains in lab tests, including many resistant to ...
Uganda is in dire need of a rethink as its HIV/Aids fight reels from a significant scale back of funds from development ...
An injection to prevent HIV is to be offered to patients on the NHS in England and Wales for the first time, bringing the ...
Africanews on MSN
New HIV prevention injection rolls out to end new cases by 2030
The injection, known as cabotegravir, is a form of pre-exposure prophylaxis (PrEP) and is administered every two months.
A 'game-changing' injection to prevent HIV is set to be approved for use in England and Wales. The long-acting jab will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback